Page last updated: 2024-08-22

magnesium sulfate and Non-alcoholic Fatty Liver Disease

magnesium sulfate has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Chang, J; Guan, X; Liu, C; Liu, J; Mao, X; Shen, S; Song, H; Song, J; Zhang, L	1

Other Studies

1 other study(ies) available for magnesium sulfate and Non-alcoholic Fatty Liver Disease

Article	Year
Protective effecs of baicalin magnesium on non-alcoholic steatohepatitis rats are based on inhibiting NLRP3/Caspase-1/IL-1β signaling pathway. BMC complementary medicine and therapies, 2023, Mar-06, Volume: 23, Issue:1 Topics: Animals; Caspase 1; Magnesium; Magnesium Sulfate; NLR Family, Pyrin Domain-Containing 3 Protein; Non-alcoholic Fatty Liver Disease; Rats; Rats, Sprague-Dawley; Signal Transduction	2023

Article

Year

Protective effecs of baicalin magnesium on non-alcoholic steatohepatitis rats are based on inhibiting NLRP3/Caspase-1/IL-1β signaling pathway.

BMC complementary medicine and therapies, 2023, Mar-06, Volume: 23, Issue:1

Topics: Animals; Caspase 1; Magnesium; Magnesium Sulfate; NLR Family, Pyrin Domain-Containing 3 Protein; Non-alcoholic Fatty Liver Disease; Rats; Rats, Sprague-Dawley; Signal Transduction

2023